Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Tech

Predictmedix to change its name to align with AI image

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced that it will be changing its corporate name to Predictmedix AI Inc, aligning the company's brand image with its innovative and AI-driven approach to revolutionizing various aspects of healthcare and safety.

The decision to incorporate ‘AI’ into the company's name highlights Predictmedix's commitment to "utilizing cutting-edge artificial intelligence technologies to enhance healthcare diagnostics, screening, workplace safety, impairment detection, and fitness screening".

In a statement, Dr Rahul Kushwah, COO of Predictmedix commented: "This name change truly reflects our core values and mission as an organization, emphasizing our dedication to utilizing artificial intelligence to transform healthcare systems, enhance workplace safety, detect impairment, and optimize performance for athletes and teams."

Predictmedix AI specializes in developing advanced AI algorithms and machine learning models that analyze diverse data sets, including facial expressions, vital signs, body language, and other biometric indicators. By harnessing the power of AI, the company has already made significant strides in various healthcare domains, including infectious disease screening and mental health assessments as well as rapid scanning of vitals.

In addition to its healthcare applications, Predictmedix AI continues to focus on workplace safety and impairment detection. By leveraging AI technologies, Predictmedix AI addresses critical challenges related to impairment caused by cannabis, alcohol, and fatigue. Its comprehensive impairment detection solutions utilize multi-modal analysis to accurately assess impairment levels in real-time, empowering organizations to proactively enhance safety protocols and prevent accidents.

Furthermore, Predictmedix AI has introduced innovative fitness screening solutions for athletes and teams. By harnessing AI-powered analysis of biometric data, the company provides in-depth insights into physical performance, enabling athletes and teams to optimize training regimens, prevent injuries, and achieve peak performance. This ground-breaking technology supports athletes and teams in making data-driven decisions, thereby enhancing their overall performance and maintaining a competitive edge.

The company said it will continue to collaborate with leading healthcare institutions, technology providers, research organizations, and sports entities to advance the boundaries of AI-driven solutions.

Predictmedix's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses.

The company's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes.

Contact the author at jon.hopkins@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK